Bryonopsis laciniosa (Linn.) Naud.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | Bryonia laciniosa Linn. Diplocyclos palmatus Jeff. |
| Family | Cucurbitaceae. |
| Habitat | Throughout India. |
| English | Bryony. |
| Ayurvedic | Lingini, Shivalingi, Chitraphalaa. |
| Siddha / Tamil | Iyaveli, Iyaviraali. |
| Folk | Lingadonda (Telugu). |
| Action | Seeds—anti-inflammatory, spasmolytic. Used for vaginal dysfunctions, as a fertility promoting drug. Powdered seeds, also roots, are given to help conception in women. Plant is also used in venereal diseases. |
| Taxonomic Cohort | Genus Bryonopsis (1 documented species); Family Cucurbitaceae (32 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Bryonopsis laciniosa (taxonomically cited with authority (Linn.) Naud.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Cucurbitaceae (primary family classification: Cucurbitaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy Bryonia laciniosa Linn. Diplocyclos palmatus Jeff, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Throughout India.
Across classical and vernacular Indian systems of medicine, Bryonopsis laciniosa is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Bryony; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Lingini, Shivalingi, Chitraphalaa; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Iyaveli, Iyaviraali; in regional Indian folk and vernacular ethnobotany as Lingadonda (Telugu). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Bryonopsis laciniosa are: Seeds—anti-inflammatory, spasmolytic. Used for vaginal dysfunctions, as a fertility promoting drug. Powdered seeds, also roots, are given to help conception in women. Plant is also used in venereal diseases. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
The therapeutic activity of Bryonopsis laciniosa is grounded in its documented pharmacological actions (Seeds—anti-inflammatory, spasmolytic. Used for vaginal dysfunctions, as a fertility promoting drug. Powdered seeds, also roots, are given to help conception in women. Plant is also used in venereal diseases) and the characteristic secondary metabolite profile of the family Cucurbitaceae.

Botanical Reference 1: Bryonopsis laciniosa — Wikimedia Commons

Botanical Reference 2: Bryonopsis laciniosa — Wikimedia Commons

Botanical Reference 3: Bryonopsis laciniosa — Wikimedia Commons
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Bryonopsis laciniosa stands as a distinct representative of the genus Bryonopsis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Cucurbitaceae encompasses 32 documented medicinal species (1.76% of the 1,814-species flora). Other representative medicinal members of Cucurbitaceae include: Benincasa hispida (Kuushmaanda), Citrullus colocynthis (Indravaaruni), Citrullus vulgaris (Kalinga), Coccinia indica (Bimbi), Corallocarpus epigaeus (Shukanaasaa). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 32 medicinal species of family Cucurbitaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Bryonopsis laciniosa follow the plant-part modalities specified under its therapeutic action (Seeds—anti-inflammatory, spasmolytic. Used for vaginal dysfunctions, as a fertility promoting drug. Powdered seeds, also roots, are given to help conception in women. Plant is also used in venereal diseases), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Bryonopsis laciniosa integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.